Lysophosphatidylcholine induces keratinocyte differentiation and upregulation of AP-1- and NF-κB DNA-binding activity

Acta Dermato-Venereologica

Volumn 84, Issue 6, 2004, Pages 433-438

  Ryborg, Ane Kaltoft ^a   Johansen, Claus ^a   Iversen, Lars ^a   Kragballe, Knud ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

AP 1; Differentiation; EMSA; Lysophosphatidylcholine; NF B; Proliferation

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYSOPHOSPHATIDYLCHOLINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN KINASE C; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; SKIN CELL; UPREGULATION;

CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KERATINOCYTES; LYSOPHOSPHATIDYLCHOLINES; NF-KAPPA B; TRANSCRIPTION FACTOR AP-1; TRANSGLUTAMINASES; UP-REGULATION;

EID: 12344320655     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550410016930     Document Type: Article

References (35)

1. Koizumi H, Kohno Y, Osada S, Ohno S, Ohkawara A, Kuroki T. Differentiation-associated localization of nPKC eta, a Ca(++)-independent protein kinase C, in normal skin and skin disease. J Invest Dermatol 1993; 101: 858-863.
2. Bell RM, Burns DJ. Lipid activation of protein kinase C. J Biol Chem 1991; 266: 4661-4664.
3. McPhail L, Clayton C, Snyderman R. A potential second messenger role for unsaturated fatty acids: activation of Ca++-dependent protein kinase. Science 1984; 224: 622-625.
4. Hannun YA, Bell RM. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science 1989; 243: 500-507.
5. Oishi K, Raynor R, Charp P, Kuo J. Regulation of protein kinase C by lysophospholipids: potential role in signal transduction. J Biol Chem 1988; 263: 6865-6871.
6. Woodley SL, Ikenouchi H, Barry WH. Lysophosphatidylcholine increases cytosolic calcium in ventrikular myocytes by direct action on the sarcolemma. J Mol Cell Cardiol 1991; 23: 671-680.
7. Yuan Y, Schoenwaelder SM, Salem HH, Jackson SP. The bioactive phospholipid lysophosphatidylcholine induces cellular effects via G-protein dependent activation of adenylyl cyclase. J Biol Chem 1996; 271: 27090-27098.
8. Wong JT, Tran K, Pierce GN, Chan AC O K, Choy PC. Lysophosphatidylcholine stimulates the release of arachidonic acid in human endothelial cells. J Biol Chem 1998; 273: 6830-6836.
9. Quinn MT, Kondratenko N, Parthasarathy S. Analysis of the monocyte chemotactic response to lysophosphatidylcholine: role of lysophospholipase C. Biochim Biophys Acta 1991; 1082: 293-302.
10. Ryborg AK, Deleuran B, Thestrup-Pedersen K, Kragballe K. Lysophosphatidylcholine: a chemoattractant to human T-lymphocytes. Arch Derm Res 1994; 286: 462-465.
11. Pietzsch A, Buchler C, Aslanidis C, Schmitz G. Identification and characterization of a novel monocyte/macrophage differentiation-dependent gene that is responsive to lipopolysaccharide, ceramide and lysophosphatidylcholine. Biochem Biophys Res Commun 1997; 235: 4-9.
12. Kume N, Gimbrone MA. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest 1994; 93: 907-911.
13. Ryborg AK, Grøn B, Kragballe K. Increased lysophosphatidylcholine content in lesional psoriatic skin. Br J Dermatol 1995; 134: 398-402.
14. Portman OW, Alexander M. Lysophosphatidylcholine concentration and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis. J Lipid Res 1969; 10: 158-165.
15. Metha D, Gupta S, Gaur SN, Gangal SV, Agrawal KP. Increased leukocyte phospholipase A2 activity and plasma lysophosphatidylcholine levels in asthma and rhinitis and their relationship to airway sensitivity to histamine. Am Rev Respir Dis 1990; 142: 157-161.
16. Hug H, Sarre TF. Protein kinase C isozymes: divergence in signal transduction. Biochem J 1993; 291: 329-343.
17. Basset-Seguin N, Demoly P, Moles JP, Tesnieres A, Gauthier-Rouviere C, Richard S, et al. Comparative analysis of cellular and tissular expression of c-fos in human keratinocytes: evidence for its role in differentiation. Oncogene 1994; 9: 765-771.
18. Disepio D, Jones A, Longley MA, Bundman D, Rothnagel JA, Roop DR. The proximal promoter of the mouse loricrin gene contains a functional AP-1 element and directs keratinocyte-specific but not differentiation-specific expression. J Biol Chem 1995; 270: 10792-10799.
19. Liu-Wu Y, Hurt-Camejo E, Wiklund O. Lysophosphatidylcholine induces the production of IL-1β by human monocytes. Atherosclerosis 1998; 137: 351-357.
20. Sugiyama S, Kugiyama K, Ogata N, Doi H, Ota Y, Ohgushi M, et al. Biphasic regulation of transcription factor nuclear factor (B activity in human endothelial cells by lysophosphatidylcholine through protein kinase C-mediated pathway. Arterioscler Thromb Vasc Biol 1998; 18: 568-576.
21. Kragballe K, Desjarlais L, Marcelo CL. Increased DNA synthesis of uninvolved psoriatic epidermis is maintained in vitro. Br J Dermatol 1985; 112: 263-270.
22. Gekeler V, Boer R, Ise W, Sanders KH, Schachtele C, Beck J. The specific bisindolylmaleimide PKC-inhibitor GF 109203X efficiently modulates MRP-associated multiple drug resistance. Biochem Biophys Res Commun 1995; 206: 119-126.
23. Gschwendt M, Muller HJ, Kielbassa K, Zang R, Kittstein W, Rincke G, et al. Rottlerin a novel protein kinase C inhibitor. Biochem Biophys Res Commun 1994; 199: 93-98.
24. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD 98059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 1995; 270: 27489-27494.
25. Casals-Stenzel J, Heuer HO. Use of WEB 2086 and WEB 2170 as platelet-activating factor antagonists. Methods Enzymol 1990; 187: 455-465.
26. Heuer HO, Casals-Stenzel J, Muacevic G, Weber KH. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepionic antagonist of platelet activating factor. J Pharmacol Exp Ther 1990; 255: 962-968.
27. Mossman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxity assays. J Immunol Methods 1986; 89: 271-277.
28. 2+ induces TG-1 expression followed by cell suicide and (2) effect of blocking retinoid acid metabolism by liarozole on TG-1 expression. J Invest Dermatol Symposium Proceedings 1996; 1: 109.
29. Rosette C, Karin M. Cytoskeletal control of gene expression: depolymerization of microtubules activates NF-κB. J Cell Biol 1995; 128: 1111-1119.
30. Nishizuka Y. Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992; 258: 607-614.
31. Dlugosz AA, Mischak H, Mushinski JF, Yuspa SH. Transcript encoding protein kinase C-α, -δ, -ε, -ξ and -ε are expressed in basal and differentiating mouse keratinocytes in vitro and exhibit quantitative changes in neoplastic cells. Mol Carcinog 1992; 5: 286-292.
32. Leibersperger H, Gschwendt M, Gernold M, Marks F. Immunological demonstration of a Ca-unresponsive protein kinase of the δ-type in different species and murine tissues. Predominance in epidermis. J Biol Chem 1991; 266: 14778-14784.
33. Koyama Y, Hachiya T, Hagiwara M, Kobayashi M, Ohashi K, Hoshino T, et al. Expression of protein kinase C-β isozyme in epidermal Langerhans cells of the mouse. J Invest Dermatol 1990; 94: 677-680.
34. Locher R, Weisser B, Mengden T, Brunner C, Vetter W. Lysolecithin actions on smooth muscle cells. Biochem Biophys Res Commun 1992; 183: 156-162.
35. Yates S, Rainer TE. Transcription factor activation in response to cutaneous injury. Wound Repair Regen 2002; 10: 5-15.